- Vienna '18
- Athens 2019
- ESCRS Player
- On Demand
- ESCRS iLearn
- ESCRS YO's
First Author: U.Emin RUSSIA
Co Author(s): B. Moukharram B. Guzel Z. Nelly B. Gulli
Back to previous
To examine the efficacy and safety of corneal ring implantation MyoRing combined with intrastromal corneal collagen crosslinking for keratoconus stage II-III
In 2007, Professor A. Daxer (Austria) proposed correcting high myopia, combined with astigmatism by MyoRing implantation in corneal stroma (CISIS - Corneal Intrastromal Implantation) [3, 5]. In 2008, provides for the use of this technique in keratoconus
Presented the two-year results of implantation of corneal implants MyoRing combined with intrastromal crosslinking with 0.1% solution of riboflavin in 17 patients (20 eyes) with keratoconus II-III stage. Dimensions MyoRing calculated from the nomogram on the basis of refraction, keratometry, and pachymetry keratotopography. Implanted corneal rings diameter waas 5-6 mm and a thickness of 240-320 ?m. After the formation of the corneal pocket conducted saturation of the cornea with 0.1% aqueous solution of riboflavin for 15 minutes. Then ring implanted and UV irradiation was performed for 25 minutes. Preoperative data were as follows: spherical component of refraction from -3.0 to -10.0 D, cylindrical from -1.0 to - 5.0 D, corneal refractive power of the average 51,6 ±2,0 D, the average thickness of the cornea 412 ±23,0 mm at the thinnest point.
Non corrected visual acuity (NCVA) increased from preoperative mean 0,09 ±0,12 to 0,3 ±0,12 at 6 months, 0,4 ±0,16 at 12 months and 0,45 ±0,15 in 2 years period (P <0,05). Refractive power of the cornea decreased from an average of 51,6 ±2,0 D to 44,0 ±2,27 D in the first months after the operation, while remaining stable in the late postoperative period and averaged 45,3 ±2,6 D in 24 months. Spherical refractive component decreased from an average of -5,75 ±1,2 D to -2,3 ±0,9 D, and cylindrical with -3,56 ±0,7 D to -1,8 ±0,8 D, radius of curvature of the cornea increased from 7 , 1 ±0,26 to 7,9 ±0,1 mm.
Implantation of corneal rings MyoRing with simultaneous intrastromal corneal crosslinking can significantly improve visual function (5 times), reduce the refractive power of the cornea by 12% and achieved stabilisation during the study period. Simplicity and reversibility makes it a safe and effective treatment.